<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Froldi F</submitter><funding>Cancer Research UK</funding><funding>Francis Crick Institute</funding><funding>Medical Research Council</funding><funding>The Francis Crick Institute</funding><funding>National Health and Medical Research Council</funding><funding>Wellcome Trust</funding><pagination>e99895</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6443203</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>38(7)</volume><pubmed_abstract>Rewired metabolism of glutamine in cancer has been well documented, but less is known about other amino acids such as histidine. Here, we use &lt;i>Drosophila&lt;/i> cancer models to show that decreasing the concentration of histidine in the diet strongly inhibits the growth of mutant clones induced by loss of Nerfin-1 or gain of Notch activity. In contrast, changes in dietary histidine have much less effect on the growth of wildtype neural stem cells and &lt;i>Prospero&lt;/i> neural tumours. The reliance of tumours on dietary histidine and also on histidine decarboxylase (Hdc) depends upon their growth requirement for Myc. We demonstrate that Myc overexpression in &lt;i>nerfin-1&lt;/i> tumours is sufficient to switch their mode of growth from histidine/Hdc sensitive to resistant. This study suggests that p</pubmed_abstract><journal>The EMBO journal</journal><pubmed_title>Histidine is selectively required for the growth of Myc-dependent dedifferentiation tumours in the &amp;lt;i&amp;gt;Drosophila&amp;lt;/i&amp;gt; CNS.</pubmed_title><pmcid>PMC6443203</pmcid><funding_grant_id>MC_U117584237</funding_grant_id><funding_grant_id>10029</funding_grant_id><funding_grant_id>104566/Z/14/Z</funding_grant_id><funding_grant_id>MC_U117533887</funding_grant_id><funding_grant_id>10088</funding_grant_id><funding_grant_id>FC001088</funding_grant_id><funding_grant_id>APP1044704</funding_grant_id><pubmed_authors>Gould AP</pubmed_authors><pubmed_authors>Froldi F</pubmed_authors><pubmed_authors>Pachnis P</pubmed_authors><pubmed_authors>Cheng LY</pubmed_authors><pubmed_authors>Szuperak M</pubmed_authors><pubmed_authors>Fernando T</pubmed_authors><pubmed_authors>Costas O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Histidine is selectively required for the growth of Myc-dependent dedifferentiation tumours in the &amp;lt;i&amp;gt;Drosophila&amp;lt;/i&amp;gt; CNS.</name><description>Rewired metabolism of glutamine in cancer has been well documented, but less is known about other amino acids such as histidine. Here, we use &lt;i>Drosophila&lt;/i> cancer models to show that decreasing the concentration of histidine in the diet strongly inhibits the growth of mutant clones induced by loss of Nerfin-1 or gain of Notch activity. In contrast, changes in dietary histidine have much less effect on the growth of wildtype neural stem cells and &lt;i>Prospero&lt;/i> neural tumours. The reliance of tumours on dietary histidine and also on histidine decarboxylase (Hdc) depends upon their growth requirement for Myc. We demonstrate that Myc overexpression in &lt;i>nerfin-1&lt;/i> tumours is sufficient to switch their mode of growth from histidine/Hdc sensitive to resistant. This study suggests that p</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2026-07-17T01:31:31.53Z</modification><creation>2019-06-06T21:04:46Z</creation></dates><accession>S-EPMC6443203</accession><cross_references><pubmed>30804004</pubmed><doi>10.15252/embj.201899895</doi></cross_references></HashMap>